NGNE neurogene.com Kompaniya foydasi

NGNE (Neurogene) - kompaniyaning tovar belgisi

Neurogene Inc. (NGNE) narxlar grafigi noyob miya patologiyalariga qarshi gen terapiyalarini ishlab chiqayotgan va nisha bozor segmentlarini egallash imkonini beruvchi kompaniyaning dinamikasini aks ettiradi. Operatsion model sinovlarni o'tkazishda tashqi pudratchilarga tayanadi, risklar esa global hamkorlarning keng tarmog'i orqali minimallashtirilgan. Joriy ko'rsatkich -0.11 darajasida bo'lib, bu bemorlar salomatligini yaxshilashga qaratilgan innovatsion strategik yo'nalishni tasdiqlaydi.

Sof daromad: Neurogene Corp (NGNE) 21.02.2024 - 30.10.2026 uchun

Neurogene (NGNE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Neurogene Therapeutics|NGNE - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Neurogene Therapeutics|NGNE - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga sof aktivlar qiymati Neurogene|NGNE - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati neurogene.com|NGNE - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Neurogene Inc.|NGNE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Neurogene Inc|NGNE - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Neurogene Therapeutics|NGNE - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Neurogene|Shoshilinch likvidlik koeffitsiyenti neurogene.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
NGNE - Sof foyda
Fundamental baholash:NGNE (Neurogene Therapeutics)
Neurogene Inc. tomonidan chiqariladigan mahsulotlar

Neurogene Inc. (NGNE) kompaniyasining iqtisodiy samaradorligi bioetik tadqiqot xarajatlari va yakuniy daromadlar o'rtasidagi muvozanatga bevosita bog'liq. Ushbu ko'rsatkich umumiy daromad va chiqindilarni utilizatsiya qilish bo'yicha ESG tashabbuslarini o'z ichiga olgan barcha operatsion xarajatlar orasidagi farq sifatida hisoblanadi. Investorlar kompaniyaning foyda hajmini tahlil qilish orqali choraklik hisobotlar orasidagi sof moliyaviy natijaning dinamikasini kuzatadilar. Ijobiy tendentsiya biznes modelining barqarorligini tasdiqlaydi, metrikaning keskin pasayishi esa ortib borayotgan xatarlardan signal beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Xenon Pharmaceuticals Inc - Sof daromad|Sof foyda Viking Therapeutics Corp VKTX|SUPN - Kompaniyaning sof foydasi|Yakuniy foyda CPRX (catalystpharma.com)|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|BHVN (Biohaven Pharmaceutical) - Sof foyda|AMLX - Yillik sof foyda|Sof foyda TRVI|PRAX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CBLL: Kompaniya foydasi|Prothena Biosciences - Sof foyda|Kompaniyaning sof daromadi Alector, Inc.|ANNX (Annexon, Inc.) - Sof daromad|Omeros - Yakuniy foyda|ACIU (AC Immune SA) - Sof foyda|Voyager Therapeutics Inc (VYGR) - Sof moliyaviy natija|Kompaniyaning sof foydasi Neumora Therapeutics Inc (NMRA)|Scilex Holding Company, Inc. - Kompaniya foydasi|Sof foyda TVGN (Tevogen Bio Holdings)|ACOG - Sof daromad|CGTX: Sof daromad|Sof moliyaviy natija Inhibikase Therapeutics Inc IKT|Cassava (SAVA) - Kompaniyaning sof foydasi|Kompaniya foydasi ASRT|COYA (Coya Therapeutics Inc) - Sof foyda|VTGN - Yillik sof foyda|Kompaniyaning sof foydasi Ovid Therapeutics Inc. (OVID)|Acumen Pharmaceuticals Inc. - Kompaniya foydasi|Sof foyda CRVO (CervoMed Inc)|Alterity Therapeutics Ltd. (ATHE) - Kompaniyaning sof daromadi|CLNN - Kompaniyaning sof foydasi|PEPG (PepGen Inc.) - Kompaniya foydasi|JUNS: Sof foyda|Kompaniyaning sof daromadi Relmada Therapeutics Inc (RLMD)|Sof daromad ANVS|Sof foyda Grace Tx|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|KLTO (anewmeds.com) - Yakuniy foyda|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Kompaniyaning sof daromadi|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Sof daromad NEUP|Sof foyda Minerva Neurosciences Inc|Kompaniyaning sof foydasi Athira (ATHA)|ADXN (Addex) - Yakuniy foyda|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|Protagenic - Sof foyda|Yillik sof foyda Pasithea Therapeutics (KTTA)|CRGT: Sof foyda|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniya foydasi CARA (caratherapeutics.com)|Sof foyda CHRO|ELYM - Kompaniyaning sof daromadi|Intra-Cellular Therapies, Inc. - Sof daromad|Yakuniy foyda LBPH|Marinus Pharmaceuticals - Sof foyda|Sof moliyaviy natija nkgenbiotech.com NKGN|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Kompaniya foydasi SAGE|SNPX (Neurotrope) - Sof foyda|Sof daromad Trevena Inc (TRVN)|Sof daromad VIGL (Vigil Neuroscience)|Sof moliyaviy natija Anew Medical Inc.|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE